Our translators have been busy, and our website is now available in Italian. Newly translated FAQ, Factsheets and Toolkit resources include the highlights listed below.
If Italian's not your language, now's your chance to have your say. We're prioritizing other languages for translation, and would like your input. Take a moment to complete our translation poll and tell us which new language you would most like to see content in.
Osteoarthritis researchers at REMEDI (Regenerative Medicine Institute) at the National University of Ireland Galway are part of a new European project which is looking to incorporate the views of patients and the general public at the earliest stages of research.
As part of the EU-funded GAMBA (Gene Activated Matrices for Bone and Cartilage Regeneration in Arthritis) project, REMEDI is looking for osteoarthritis patients who would like to learn about new therapy approaches and are willing to evaluate theses approaches from a patient’s point of view. The patients should be residents in Galway, be at least 18 years old and available for four days in March 2012. The views of the general public will be sought in early summer.
** Part III of Behind the Bench: A series about researchers and their rituals, by Anestis Tsakiridis **
The framework of a scientific story, which comprises a researcher’s vehicle to communicate personally-derived snippets of knowledge to colleagues, funders and the public, relies heavily on the choreographed assembly of data or “Results”. These are the building blocks of PhD theses, research articles, talks and grant proposals and thus hold an almost divine status in the minds and hearts of scientists. A “Result” can be anything: a number, a graph, an image, a statistical variation in a sea of data. It is the distillation of the empirical component of a researcher’s job, the visible product of manual work that, in the case of stem cell science, normally takes place inside laboratories and tissue culture hoods. Results are born out of questions and curiosity, both critical factors contributing to the design of a series of experiments aiming to shed light on the different facets of a hypothesis.
Ever thought about talking to school students about your work and wondered if its for you? PhD student Kerstin Schmidt has been giving it a go...
During the first year of my PhD thesis I came more and more to realize that it is important to communicate my own research to others and to raise awareness of scientific questions. With this in mind, I seized the opportunity to join the schools’ outreach project run by the Dresden International PhD Program. I was quite nervous in the beginning. How would the students react? Would they like it? And would I be able to pass on some of my enthusiasm about molecular sciences to 15–16 year old students who are just about to decide what they want to do with their lives?
Before new treatments can reach patients, they must be tested in clinical trials. This is our second brief update on some stem-cell-related trials currently under way or recently approved.
This update looks at trials for amyotrophic lateral sclerosis (ALS) or motor neurone disease, as well as the latest news on how the trials we told you about in September are progressing. We’ve included details of one or two new trials for some of the conditions we focussed on last time: spinal injury, Stargardt’s macular dystrophy and stroke. We’ll post more updates on other themes in future, so tell us if there’s an area you really want to know about.
Over 100 Italian and UK scientists and politicians came together on 12th December for a Summit on Regenerative Medicine organized by the Italian Embassy in London and the School of Science Technology and Health, University Campus Suffolk. Their aim: to bring the collective expertise of academics, industry and the political world to bear on the question of how to take basic stem cell research towards the clinic.
Meet our new guest blogger, Alzheimer's disease researcher Selina Wray...
I’ve had some great feedback since starting my blog at www.whatsyourlifelike.com and I was particularly excited to receive an e-mail from EuroStemCell this morning to ask if I would write for them too. This will be the first post that will be cross-posted across both sites and so I thought I would write a brief introduction for any new readers who have come here through an interest in stem cells.
Wellcome Trust, the largest independent charity in the United Kingdom, has just announced that it will support the Debating Science Issues (DSI) project for a fifth consecutive year with a People Award.
DSI is an Ireland-Northern Ireland cross border schools’ science debating competition involving 9 collaborating partners: the Regenerative Medicine Institute (REMEDI) at National University of Ireland Galway, W5 in Belfast, Biomedical Diagnostics Institute (BDI) at Dublin City University, Royal College of Surgeons Ireland, CRANN at Trinity College, CLARITY at UCD, the Centre for Cross Border Studies in Armagh, Cork Institute of Technology and Alimentary Pharmabiotic Centre at UCC.
Andrew Smith tweeted from a recent NeuroStemcell workshop on Stem cell therapy for neurological diseases: translation to the clinic. We've collated his tweets with links to some of the things discussed using Storify, to preserve a record of the workshop and for those who missed the original tweets.
 |  |
© Copyright 2008-2012 EuroStemCell and contributing authors
